Aspen Aerogels (NYSE:ASPN) Reaches New 12-Month Low - Should You Sell?

Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $7.45 and last traded at $7.50, with a volume of 2443166 shares trading hands. The stock had previously closed at $7.77.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on ASPN shares. Barclays reduced their price objective on Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating on the stock in a research note on Wednesday, February 19th. StockNews.com raised Aspen Aerogels to a "sell" rating in a research note on Wednesday, February 19th. Canaccord Genuity Group reduced their price objective on Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating on the stock in a research note on Friday, February 14th. Roth Mkm cut their target price on Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating on the stock in a research note on Friday, February 14th. Finally, Craig Hallum cut their target price on Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating on the stock in a research note on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $22.44.

Remove Ads

Aspen Aerogels Stock Up 0.6 %

The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The company's fifty day simple moving average is $11.16 and its 200 day simple moving average is $17.61. The firm has a market capitalization of $622.98 million, a PE ratio of 47.46 and a beta of 2.14.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. Analysts anticipate that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current fiscal year.

Institutional Trading of Aspen Aerogels

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Toronto Dominion Bank purchased a new stake in Aspen Aerogels in the fourth quarter worth about $266,000. AWM Investment Company Inc. lifted its holdings in shares of Aspen Aerogels by 2.9% during the fourth quarter. AWM Investment Company Inc. now owns 1,208,686 shares of the construction company's stock valued at $14,359,000 after purchasing an additional 34,115 shares during the last quarter. Connective Capital Management LLC purchased a new position in shares of Aspen Aerogels during the fourth quarter valued at approximately $433,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Aspen Aerogels by 47.3% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 588,395 shares of the construction company's stock valued at $6,990,000 after purchasing an additional 188,861 shares during the last quarter. Finally, Voloridge Investment Management LLC purchased a new position in shares of Aspen Aerogels during the fourth quarter valued at approximately $3,089,000. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.